Market Overview

Gabelli Healthcare & WellnessRx Trust Raises Its Quarterly Distribution Rate to $0.14 Per Share from $0.13 Per Share


The Board of Trustees of The Gabelli Healthcare & WellnessRx
Trust (NYSE:GRX) (the "Fund") reaffirmed its quarterly distribution
policy and raised the quarterly cash distribution to $0.14 per share,
which represents an 8% increase from $0.13 per share paid in the prior
quarter, payable on March 22, 2019 to common shareholders of record on
March 15, 2019.

The Fund intends to pay a quarterly distribution of an amount determined
each quarter by the Board of Trustees. The Board of Trustees may change
the amount of the quarterly distribution at any time. In addition to the
quarterly distributions, and in accordance with the minimum distribution
requirements of the Internal Revenue Code for regulated investment
companies, the Fund may pay an adjusting distribution which includes any
additional income and net realized capital gains in excess of the
quarterly distributions for that year.

Each quarter, the Board of Trustees reviews the amount of any potential
distribution and the income, realized capital gain, or capital
available. The Board of Trustees will continue to monitor the Fund's
distribution level, taking into consideration the Fund's net asset value
and the financial market environment. The Fund's distribution policy is
subject to modification or termination by the Board of Trustees at any
time, and there can be no guarantee that the policy will continue. The
distribution rate should not be considered the dividend yield or total
return on an investment in the Fund.

All or part of the distribution may be treated as long-term capital gain
or qualified dividend income (or a combination of both) for individuals,
each subject to the maximum federal income tax rate, which is currently
20% in taxable accounts for individuals (or less depending on an
individual's tax bracket). In addition, certain U.S. shareholders who
are individuals, estates or trusts and whose income exceeds certain
thresholds will be required to pay a 3.8% Medicare surcharge on their
"net investment income", which includes dividends received from the Fund
and capital gains from the sale or other disposition of shares of the

If the Fund does not generate sufficient earnings (dividends and
interest income and realized net capital gain) equal to or in excess of
the aggregate distributions paid by the Fund in a given year, then the
amount distributed in excess of the Fund's earnings would be deemed a
return of capital. Because this would be considered a return of a
portion of a shareholder's original investment, it is generally not
taxable and would be treated as a reduction in the shareholder's cost

Long-term capital gains, qualified dividend income, ordinary income, and
return of capital, if any, will be allocated on a pro-rata basis to all
distributions to common shareholders for the year. Based on the
accounting records of the Fund currently available, the current
distribution paid to common shareholders in 2019 would include
approximately 38% from net capital gains and 62% would be deemed a
return of capital on a book basis. This does not represent information
for tax reporting purposes. The estimated components of each
distribution are updated and provided to shareholders of record in a
notice accompanying the distribution and are available on our website (
The final determination of the sources of all distributions in 2019 will
be made after year end and can vary from the quarterly estimates.
Shareholders should not draw any conclusions about the Fund's investment
performance from the amount of the current distribution. All
shareholders with taxable accounts will receive written notification
regarding the components and tax treatment for all 2019 distributions in
early 2020 via Form 1099-DIV.

Investors should carefully consider the investment objectives, risks,
charges, and expenses of the Fund before investing.
information regarding the Fund's distribution policy and other
information about the Fund is available by calling 800-GABELLI
(800-422-3554) or visiting

The Gabelli Healthcare & WellnessRx Trust is a
diversified, closed-end management investment company with $296 million
in total net assets whose primary investment objective is long-term
growth of capital. The Fund is managed by Gabelli Funds, LLC, a
subsidiary of GAMCO Investors, Inc. (NYSE:GBL).

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at